BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2588923)

  • 1. Survival of patients with malignancy-associated effusions.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1989; 33(6):911-6. PubMed ID: 2588923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural effusions. A clinical cytopathologic study.
    Irani DR; Underwood RD; Johnson EH; Greenberg SD
    Arch Intern Med; 1987 Jun; 147(6):1133-6. PubMed ID: 3592878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural effusion in breast cancer: influence upon clinical course and survival.
    Singer TS; Sulkes A; Biran S
    Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
    Vignale L; Galli G; Rossi PC; Parentini GC
    Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
    Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patient with pleural involvement by breast carcinoma.
    Poe RH; Qazi R; Israel RH; Wicks CM; Rubins JM
    Am J Clin Oncol; 1983 Oct; 6(5):523-7. PubMed ID: 6613918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytodiagnosis of pleural effusions. III. Neoplastic effusions with special reference to the relationship between cytomorphology and primary site of the tumor].
    Dini S; Colafranceschi M; Taddei GL; Montigiani C
    Arch De Vecchi Anat Patol; 1977 Dec; 62(2-3):611-8. PubMed ID: 756237
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local administration of recombinant interferon-beta to patients with cancer-associated body cavity fluids].
    Tanaka N; Terasawa A; Matsui T; Yamada J; Hizuta A; Ichikawa J; Nakayama F; Matsuda T; Orita K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):237-41. PubMed ID: 3341785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and prognostic significance of massive pleural effusions.
    Jiménez D; Díaz G; Gil D; Cicero A; Pérez-Rodríguez E; Sueiro A; Light RW
    Respir Med; 2005 Sep; 99(9):1183-7. PubMed ID: 16085221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effusion cytology.
    Ehya H
    Clin Lab Med; 1991 Jun; 11(2):443-67. PubMed ID: 1873966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural effusions.
    Dhillon DP; Spiro SG
    Br J Hosp Med; 1983 Jun; 29(6):506-8, 510. PubMed ID: 6307448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.